L. J. Pastor-Quirós and E. P. Correa-Díaz, “The budgetary impact of alemtuzumab in multiple sclerosis in Quito, Ecuador. Payer’s perspective”, Grhta, vol. 8, no. 1, pp. 140–146, Oct. 2021.